A newly approved antivenin should save people bitten by rattlesnakes in the
US. 鈥淲e hope that it works faster and with fewer side effects,鈥 says Arthur
Rushton of Protherics, the British company that developed the treatment.
Rattlesnakes bite thousands of Americans each year. The existing antivenin,
derived from horses, often leads to a fever called serum sickness. The new
treatment contains purified sheep antibodies against venom from the four major
US rattlers, and so is free of the protein impurities thought to cause serum
sickness (New Scientist, 3 February 1996, p 18).
More from New Scientist
Explore the latest news, articles and features
Technology
Test moderators use AI-generated writing to judge literacy standards
News
Mind
THC in cannabis may reduce nightmares in people with PTSD
News
Environment
Fishers detonate a bomb every hour on one Indonesian coral reef
News
Environment
How bad is the UK drought and how long will it continue?
News
Popular articles
Trending New Scientist articles